What's Powering J&J's MedTech Growth Ahead of Q4 Release?
J&J(US:JNJ) ZACKS·2026-01-13 13:50Key Takeaways J&J's MedTech sales improved for two straight quarters, led by Cardiovascular, Surgery and Vision businesses.J&J's Cardiovascular segment rose 17.4% in the first nine months of 2025, boosted by Abiomed and Shockwave.J&J expects continued MedTech momentum despite China VBP pressure, with growth driven by new product adoption.Johnson & Johnson's (JNJ) medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment acc ...